Page last updated: 2024-08-26

deoxypyridinoline and etidronate

deoxypyridinoline has been researched along with etidronate in 31 studies

Research

Studies (31)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (29.03)	18.2507
2000's	19 (61.29)	29.6817
2010's	3 (9.68)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altman, R; Conte, JM; Favus, M; Lombardi, A; Lyles, K; McIlwain, H; Murphy, WA; Reda, C; Rude, R; Seton, M; Siris, E; Thompson, D; Tiegs, R; Tucci, JR; Weinstein, RS; Yates, AJ; Zimering, M	1
Bettica, P; Bevilacqua, M; Cucinotta, E; Masino, M; Norbiato, G; Vago, T	1
Polo, RM; Rubinacci, A; Sirtori, P; Sosio, C; Tenni, R	1
Bekker, PJ; Charles, P; Digennaro, J; Johnston, CC; Mortensen, L	1
Bryant, C; Campbell, J; Diamond, T; Lynch, W	1
Addesso, V; Lo, SH; Mancini, D; McMahon, DJ; Michler, RE; Rodino, MA; Seibel, MJ; Shane, E; Staron, RB	1
Becker, P; Watts, NB	1
Barton, I; Bonvoisin, B; Cortet, B; Hachulla, E; Roux, C	1
Imai, Y; Itoh, F; Kojima, M; Komatsu, H; Komatsu, Y; Shiraki, M; Taya, F	1
Endo, M; Fujita, T; Hidaka, M; Ohi, H; Ohsawa, I; Satomura, A	1
Balena, R; Blake, GM; Fogelman, I; Herd, RJ	1
Adami, S; Balena, R; Becorpi, A; Bianchini, D; Bruni, V; Campagnoli, C; Ferrari, A; Lombardi, P; Marchesoni, T	1
Digennaro, J; Fall, P; Raisz, L; Sacco-Gibson, N; Shoukri, K; Smith, JA; Trahiotis, M	1
Eun, SS; Hasegawa, C; Ikai, T; Kimura, C; Miyano, S; Uematsu, M	1
Ichimura, S; Iwamoto, J; Katsumata, T; Takeda, T; Tanaka, T; Toyama, Y	1
Hasegawa, J; Katsumata, S; Nagashima, M; Nishijima, T; Yamamoto, M; Yoshino, S	1
Fukunaga, M; Inoue, T; Kishimoto, H; Kushida, K; Minaguchi, H; Morii, H; Morita, R; Ohashi, Y; Orimo, H; Shiraki, M; Taketani, Y; Yamamoto, K	1
Kitatani, K; Miki, T; Morii, H; Naka, H; Nakatsuka, K; Nishizawa, Y	1
Callaci, JJ; Frost, N; Juknelis, D; Patwardhan, A; Sartori, M; Wezeman, FH	1
Barton, I; Grauer, A; Naganathan, V; Seibel, MJ	1
Ikeda, S; Ito, M; Nakamura, T; Otomo, H; Phipps, RJ; Sakai, A; Tanaka, S	1
Fukunaga, M; Inoue, T; Itabashi, A; Kaneda, K; Kishimoto, H; Kushida, K; Morii, H; Nawata, H; Ohashi, Y; Orimo, H; Shiraki, M; Yamamoto, K	1
Sarioglu, M; Taneli, F; Tikiz, C; Tuzun, C; Unlu, Z; Uyanik, BS	1
Capar, M; Köşüş, A; Köşüş, N	1
Nagashima, M; Shue, G; Yamamoto, K; Yoshino, S	1
D'Emden, M; Ebeling, PR; Ernst, TF; Graham, JJ; Hooper, MJ; Nicholson, GC; Roberts, AP; Wenderoth, D	1
Honda, Y; Iwamoto, J; Sato, Y	1
Allen, MR; Burr, DB; Delmas, PD; Gineyts, E; Leeming, DJ	1
Furukawa, F; Hata, M; Hattori, M; Ikeda, T; Kaminaka, C; Kanazawa, N; Nishide, T; Ohta, C; Tsujioka, K; Uede, K; Yamamoto, Y	1
Izumi, K; Kitagawa, Y; Koh, E; Mizokami, A; Namiki, M; Narimoto, K; Sugimoto, K	1
Gulseren, A; Peyman, B; Pinar, A	1

Trials

22 trial(s) available for deoxypyridinoline and etidronate

Article	Year
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Amino Acids; Biopsy; Bone and Bones; Calcium; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pain; Phosphates; Radiography	1996
Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:9 Topics: Adult; Alendronate; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Carbonate; Collagen; Collagen Type I; Diphosphonates; Drug Administration Schedule; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Peptides; Time Factors	1997
Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:2 Topics: Adult; Alkaline Phosphatase; Amino Acids; Bone Density; Calcium Channel Blockers; Creatinine; Double-Blind Method; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Postmenopause; Risedronic Acid; Time Factors	1998
Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate. Bone, 1999, Volume: 24, Issue:1 Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Amino Acids; Bone Density; Drug Administration Schedule; Etidronic Acid; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Treatment Outcome	1999
Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study. Revue du rhumatisme (English ed.), 1999, Volume: 66, Issue:4 Topics: Absorptiometry, Photon; Alkaline Phosphatase; Amino Acids; Arthritis, Rheumatoid; Bone Density; Double-Blind Method; Drug Evaluation; Etidronic Acid; Female; Femur; Giant Cell Arteritis; Glucocorticoids; Humans; Lumbosacral Region; Male; Middle Aged; Osteocalcin; Osteoporosis; Polymyalgia Rheumatica; Spine	1999
Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy. Calcified tissue international, 2000, Volume: 66, Issue:3 Topics: Adolescent; Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Calcium; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etidronic Acid; Female; Glucocorticoids; Humans; Male; Middle Aged; Nephrotic Syndrome; Osteocalcin; Phosphorus; Prednisolone; Time Factors	2000
Cyclical etidronate therapy for prevention of postmenopausal bone loss: a 1-year open-label follow-up study. Calcified tissue international, 2000, Volume: 66, Issue:5 Topics: Amino Acids; Biomarkers; Bone Density; Bone Remodeling; Double-Blind Method; Drug Administration Schedule; Etidronic Acid; Female; Femur Neck; Follow-Up Studies; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Spine; Time Factors	2000
Prevention of early postmenopausal bone loss with cyclical etidronate. Journal of endocrinological investigation, 2000, Volume: 23, Issue:5 Topics: Absorptiometry, Photon; Amino Acids; Bone Density; Double-Blind Method; Etidronic Acid; Female; Femur; Humans; Middle Aged; Osteoporosis, Postmenopausal; Periodicity; Placebos; Spine; Treatment Outcome	2000
Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2000, Volume: 11, Issue:7 Topics: Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Remodeling; Calcium Channel Blockers; Cohort Studies; Collagen; Collagen Type I; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Peptides; Postmenopause; Procollagen; Risedronic Acid	2000
Prevention of secondary osteoporosis postmenopause in hemiplegia. American journal of physical medicine & rehabilitation, 2001, Volume: 80, Issue:3 Topics: Absorptiometry, Photon; Activities of Daily Living; Aged; Alkaline Phosphatase; Amino Acids; Bone Density; Disease Progression; Etidronic Acid; Female; Follow-Up Studies; Geriatric Assessment; Hemiplegia; Humans; Osteocalcin; Osteoporosis, Postmenopausal; Radionuclide Imaging	2001
Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. The Journal of rheumatology, 2003, Volume: 30, Issue:3 Topics: Aged; Alkaline Phosphatase; Amino Acids; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone Density; Bone Resorption; C-Reactive Protein; Etidronic Acid; Female; Humans; Interleukin-6; Male; Middle Aged; Severity of Illness Index	2003
A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2003, Volume: 14, Issue:3 Topics: Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Etidronic Acid; Female; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Osteoporosis, Postmenopausal; Risedronic Acid; Treatment Outcome	2003
Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy. Journal of bone and mineral metabolism, 2003, Volume: 21, Issue:4 Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity; Treatment Outcome	2003
Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:2 Topics: Aged; Amino Acids; Bone Density; Bone Resorption; Etidronic Acid; Female; Humans; Incidence; Osteoporosis; Placebos; Postmenopause; Risedronic Acid; Spinal Fractures	2004
A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial. Journal of bone and mineral metabolism, 2004, Volume: 22, Issue:5 Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Body Height; Bone and Bones; Collagen; Collagen Type I; Etidronic Acid; Female; Humans; Incidence; Japan; Osteoporosis, Postmenopausal; Peptides; Quality of Life; Risedronic Acid; Spinal Fractures; Surveys and Questionnaires	2004
Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis. Rheumatology international, 2006, Volume: 26, Issue:3 Topics: Aged; Alendronate; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcium; Creatinine; Double-Blind Method; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Risedronic Acid	2006
Cyclical alendronate treatment in postmenopausal women with osteoporosis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 91, Issue:2 Topics: Alendronate; Alkaline Phosphatase; Amino Acids; Bone Density; Bone Density Conservation Agents; Calcium; Drug Administration Schedule; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphorus	2005
Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3 Topics: Absorptiometry, Photon; Adult; Amino Acids; Biomarkers; Bone Density Conservation Agents; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Risedronic Acid; Treatment Outcome	2005
Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology, 2007, Mar-20, Volume: 68, Issue:12 Topics: Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Resorption; Double-Blind Method; Ergocalciferols; Etidronic Acid; Hip Fractures; Humans; Hyperparathyroidism; Male; Osteoporosis; Parkinson Disease; Placebo Effect; Prospective Studies; Risedronic Acid; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin D Deficiency	2007
Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy. Clinical and experimental dermatology, 2011, Volume: 36, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density Conservation Agents; Etidronic Acid; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Sex Factors; Skin Diseases; Treatment Outcome; Young Adult	2011
Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study. Prostate cancer and prostatic diseases, 2011, Volume: 14, Issue:3 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Androgen Antagonists; Antineoplastic Agents; Biomarkers; Bone Density; Bone Density Conservation Agents; Etidronic Acid; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Lost to Follow-Up; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Radiography; Risedronic Acid	2011
Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. Panminerva medica, 2011, Volume: 53, Issue:2 Topics: Aged; Amino Acids; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen Type I; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Osteoprotegerin; Postmenopause; Risedronic Acid; Vitamin D	2011

Other Studies

9 other study(ies) available for deoxypyridinoline and etidronate

Article	Year
A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women. Pharmacological research, 1997, Volume: 36, Issue:3 Topics: Aged; Amino Acids; Biomarkers; Bone Resorption; Collagen; Estrogen Replacement Therapy; Etidronic Acid; Female; Humans; Hydroxylysine; Middle Aged; Postmenopause	1997
The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer, 1998, Oct-15, Volume: 83, Issue:8 Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Amino Acids; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone and Bones; Bone Density; Calcium; Carcinoma; Drug Administration Schedule; Etidronic Acid; Evaluation Studies as Topic; Femur Neck; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Testosterone; Tomography, X-Ray Computed; Vitamin D	1998
Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1998, Volume: 17, Issue:11 Topics: Absorptiometry, Photon; Amino Acids; Biomarkers; Bone Density; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Fractures, Bone; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Osteoporosis; Pamidronate; Parathyroid Hormone; Pilot Projects; Vitamin D	1998
Treatment effects of bisphosphonates on ovariectomy-induced osteopenia in rats: comparison between clodronate and etidronate. Journal of bone and mineral metabolism, 1999, Volume: 17, Issue:4 Topics: Amino Acids; Animals; Bone Density; Bone Diseases, Metabolic; Calcium; Clodronic Acid; Etidronic Acid; Female; Lumbar Vertebrae; Ovariectomy; Rats; Rats, Sprague-Dawley	1999
Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats. Bone, 2002, Volume: 30, Issue:2 Topics: Age Factors; Amino Acids; Animals; Body Weight; Bone Density; Bone Resorption; Denervation; Etidronic Acid; Femur; Male; Orchiectomy; Osteocalcin; Osteoporosis; Rats; Rats, Wistar; Sciatic Nerve; Tibia	2002
The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment. Alcoholism, clinical and experimental research, 2004, Volume: 28, Issue:1 Topics: Amino Acids; Animals; Biomechanical Phenomena; Bone Density; Bone Resorption; Diphosphonates; Ethanol; Etidronic Acid; Male; Rats; Rats, Sprague-Dawley; Risedronic Acid	2004
Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. Journal of bone and mineral metabolism, 2004, Volume: 22, Issue:5 Topics: Absorptiometry, Photon; Amino Acids; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Matrix; Etidronic Acid; Female; Femur; Lumbar Vertebrae; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Risedronic Acid; Spectroscopy, Fourier Transform Infrared; Tomography, X-Ray Computed; Vitamin K 2	2004
Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models. Rheumatology international, 2006, Volume: 26, Issue:7 Topics: Aged; Alkaline Phosphatase; Amino Acids; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Bone Resorption; Etidronic Acid; Female; Humans; Interleukin-6; Male; Middle Aged	2006
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Volume: 19, Issue:3 Topics: Alendronate; Amino Acids; Animals; Arginine; Bone Density Conservation Agents; Bone Remodeling; Collagen; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Etidronic Acid; Female; Lumbar Vertebrae; Lysine; Raloxifene Hydrochloride; Risedronic Acid	2008